NCT00113477View on ClinicalTrials.gov

The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Statin Therapy

Interventions

DRUG

Q10

DRUG

Selen

Trial Locations (1)

0027

Lipidklinikken, Rikshospitalet, Oslo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pharma Nord

INDUSTRY

lead

Oslo University Hospital

OTHER

NCT00113477 - The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy | Biotech Hunter | Biotech Hunter